Genmab A/S. (6/10/20). "Press Release: Genmab and AbbVie Announce Broad Oncology Collaboration". Copenhagen & North Chicago, IL. |
2020-06-10 |
Bioqube Ventures. (6/10/20). "Press Release: Bioqube Ventures Launches Bioqube Factory Fund I". Hasselt/Brussels. |
2020-06-10 |
Valo Therapeutics Ltd.. (6/8/20). "Press Release: Valo Therapeutics Announces Board Appointment of Dr Mai-Britt Zocca". Oxford & Helsinki. |
2020-06-08 |
Boehringer Ingelheim. (6/8/20). "Press Release: New Consortium EUbOPEN Will Provide Tools to Unlock Disease Biology. 66 Million Euros to Generate Open-access Chemical Tools". Frankfurt & Ingelheim. |
2020-06-08 |
Calliditas Therapeutics AB. (6/5/20). "Press Release: Calliditas Therapeutics Prices Its Initial Public Offering on The Nasdaq Global Select Market in the United States". |
2020-06-05 |
Immatics Biotechnologies GmbH. (6/4/20). "Press Release: Immatics Appoints Cedrik Britten as Chief Medical Officer". Houston, TX & Tübingen. |
2020-06-04 |
Novo Holdings A/S. (6/3/20). "Press Release: Novo Ventures Leads US$55m Series B Investment in NodThera". Copenhagen. |
2020-06-03 |
Exact Therapeutics AS. (6/3/20). "Press Release: Norwegian Exact Therapeutics Appoints Dr. Rafiq Hasan as CEO". |
2020-06-03 |
Albumedix Ltd.. (6/1/20). "Press Release: Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer". |
2020-06-01 |
Rentschler Biopharma SE. (5/27/20). "Press Release: Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility". Laupheim & Milford, MA. |
2020-05-27 |
Exscientia Ltd.. (5/26/20). "Press Release: Exscientia Raises $60 Million in Series C Financing Round Led by Novo Holdings". Oxford, Copenhagen & Hamburg. |
2020-05-26 |
Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer". |
2020-05-26 |
Cyxone AB. (5/20/20). "Press Release: Dr Tara Heitner Appointed New CEO for Cyxone". |
2020-05-20 |
Elekta. (5/19/20). "Press Release: Acquisition of Kaiku Health Strengthens Elekta Digital Offering with Personalized Digital Health Interventions". Stockholm. |
2020-05-19 |
Roche. (5/15/20). "Press Release: Roche Launches New Blood Gas Digital Solution Designed to Improve Patient Care". Basel. |
2020-05-15 |
Calliditas Therapeutics AB. (5/14/20). "Press Release: Calliditas Publicly Files Registration Statement with SEC for a Proposed Initial Public Offering in the United States". |
2020-05-14 |
Innovative Medicines Initiative (IMI). (5/12/20). "Press Release: IMI Announces COVID Projects, Boosts Funding Pot to EUR 72 million". Brussels. |
2020-05-12 |
Aqilion AB. (5/11/20). "Press Release: Torgeir Vaage Joins Aqilion as Chief Financial Officer". Helsingborg. |
2020-05-11 |
Ascendis Pharma A/S. (5/11/20). "Press Release: Ascendis Pharma A/S Will Appoint Jesper Høiland as Global Chief Commercial Officer". Copenhagen. |
2020-05-11 |
Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Announces First Quarter 2020 Financial Results". South San Francisco, CA. |
2020-05-07 |
Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services". South San Francisco, CA. |
2020-05-07 |
Oncopeptides AB. (5/6/20). "Press Release: Oncopeptides Has Completed a Directed Share Issue Raising approximately SEK 1,414 Million (USD 144 M) [NOT FOR US, AU, CA, et al.]". Boston, MA. |
2020-05-06 |
[iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. |
2020-05-04 |
Biograil ApS. (4/30/20). "Press Release: Biograil Announces Sanner Ventures Has Joined Investor Syndicate". Copenhagen. |
2020-04-30 |
EnginZyme AB. (4/22/20). "Press Release: EnginZyme Secures €6.4 Million Series A Financing Round Led by Sofinnova Partners". Stockholm. |
2020-04-22 |
Avectas Ltd.. (4/16/20). "Press Release: Avectas Completes Significant Series C Funding Bringing Total Invested Equity to Over $40 Million". Dublin. |
2020-04-16 |
Leo Pharma A/S. (4/15/20). "Press Release: Leo Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate". Ballerup. |
2020-04-15 |
Neuro Event Labs Oy. (4/8/20). "Press Release: Neuro Event Labs Closes €3.9M Series A Round to Become the Standard for Epilepsy Diagnostics". |
2020-04-08 |
Symphogen A/S. (4/3/20). "Press Release: Servier Signed a Definitive Agreement to Acquire Symphogen, a Leading Antibody Discovery Company, to Boost Its Antibody Capabilities and Leverage Its R&D Pipeline". Paris & Copenhagen. |
2020-04-03 |
Apeiron Biologics AG. (4/2/20). "Press Release: Apeiron Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19". Vienna. |
2020-04-02 |
Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 Million ($450 Million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. |
2020-03-31 |
Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. |
2020-03-27 |
H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Reports Headline Results from Phase IIa AMBLED study of Foliglurax in Parkinson’s Disease". Valby. |
2020-03-27 |
H. Lundbeck A/S. (3/27/20). "Press Release: Lundbeck Announces Phase IIa Study Results of Lu AG06466 in Adults with Tourette Syndrome". Valby. |
2020-03-27 |
Oxford Biomedica plc. (3/18/20). "Press Release: Building the Group for Future Growth. Business Update". Oxford. |
2020-03-18 |
ImCheck Therapeutics SAS. (3/17/20). "Press Release: ImCheck Therapeutics Expands Leadership Team with Appointment of Hans Henrik Chrois Christensen as Chief Financial Officer and Chief Operating Officer". Marseille. |
2020-03-17 |
Tempus Labs, Inc.. (3/13/20). "Press Release: Tempus Announces $100 Million in Series G Financing". |
2020-03-13 |
Lysogene S.A.. (3/12/20). "Press Release: Lysogene Completes €7.7 Million Capital Increase in a Placement Led by Leading Healthcare Investor OrbiMed and Lysogene Shareholder and Partner Sarepta [Not for US, CA, AU or JP]". Paris. |
2020-03-12 |
Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. |
2020-03-10 |
Alligator Bioscience AB. (3/5/20). "Press Release: Alligator Bioscience Appoints Andreas Johannesson as Interim Chief Financial Officer". Lund. |
2020-03-05 |
Agilent Technologies Inc.. (3/2/20). "Press Release: Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions". Santa Clara, CA & Copenhagen. |
2020-03-02 |
Fluidigm Corporation. (2/26/20). "Press Release: Fluidigm Completes Acquisition of InstruNor AS". South San Francisco, CA. |
2020-02-26 |
Genedata AG. (2/26/20). "Press Release: Leading Biopharma Experts Drive R&D Innovation and Process Efficiency at the Genedata Partner Symposium". Basel. |
2020-02-26 |
FinnGen. (2/25/20). "Press Release: FinnGen Welcomes Janssen and Maze Therapeutics". |
2020-02-25 |
DSM N.V.. (2/21/20). "Press Release: DSM to Acquire Glycom to Accelerate Growth in Early Life Nutrition". Heerlen. |
2020-02-21 |
Sundew ApS. (2/19/20). "Press Release: Sundew Awarded GUDP Grant". |
2020-02-19 |
Optibrium Ltd.. (2/17/20). "Press Release: Optibrium Appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development". Cambridge. |
2020-02-17 |
Alligator Bioscience AB. (2/12/20). "Press Release: Alligator Bioscience AB Year-end Report January-December 2019". |
2020-02-12 |
Nanoform Finland Oyj. (2/10/20). "Press Release: Nanoform Establishes US Subsidiary". Helsinki. |
2020-02-10 |
Orphazyme A/S. (2/7/20). "Press Release: Orphazyme Completes Offering of 7,032,937 Shares in a Directed Issue and Private Placement and Raises approximately DKK 745,000,000 (EUR 100 Million / USD 110 Million) [Not for US, CA, JP or AU]". Copenhagen. |
2020-02-07 |
GeNeuro S.A.. (1/31/20). "Press Release: GeNeuro Announces Successful €17.5 Million Private Placement [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Geneva. |
2020-01-31 |
CureVac AG. (1/31/20). "Press Release: CureVac and CEPI Extend Their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019". Tübingen & Boston, MA & Oslo. |
2020-01-31 |
Orion Corporation. (1/31/20). "Press Release: Positive CHMP Opinion for Darolutamide as a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer". |
2020-01-31 |
PepGen Ltd.. (1/30/20). "Press Release: PepGen Joins Forces with Researchers to Tackle Brain Comorbidity in DMD". |
2020-01-30 |
Saga Diagnostics AB. (1/28/20). "Press Release: Saga Diagnostics Extends Its Collaboration with Servier to Use Ultrasensitive SAGAsafe Technology in Cancer Clinical Trials". Lund. |
2020-01-28 |
Elypta AB. (1/23/20). "Press Release: Elypta Raises €6.1 Million in a Late Seed Round Led by Industrifonden". |
2020-01-23 |
Orion Corporation. (1/23/20). "Press Release: Marketing Authorization Granted for Darolutamide in Japan". |
2020-01-23 |
Blueprint Genetics Oy. (1/22/20). "Press Release: Quest Diagnostics Acquires Blueprint Genetics to Broaden Access to Actionable Insights for Genetic and Rare Diseases". |
2020-01-22 |
HepaRegenix GmbH. (1/21/20). "Press Release: HepaRegenix GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic". Tübingen. |
2020-01-21 |
Qlucore AB. (1/21/20). "Press Release: Qlucore Moves into New Business Areas and Expands Board". |
2020-01-21 |
Coulter Partners. (1/21/20). "Press Release: Coulter Partners Secures Head of US Sales for Nanoform". |
2020-01-21 |
Novo Holdings A/S. (1/21/20). "Press Release: Novo Seeds Portfolio Company HepaRegeniX GmbH Secures Series B Financing in Excess of EUR 11 Million". Copenhagen. |
2020-01-21 |
Cognate Bioservices, Inc.. (1/21/20). "Press Release: Cognate BioServices Closes Series B and Completes Acquisition of Cobra Biologics". Memphis, TN. |
2020-01-21 |
High-Tech Gründerfonds Management GmbH. (1/15/20). "Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables". |
2020-01-15 |
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. |
2020-01-14 |
Nanoform Finland Oyj. (1/13/20). "Press Release: Nanoform Appoints Head of US Sales". Helsinki. |
2020-01-13 |
Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain. |
2020-01-09 |
NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. |
2020-01-08 |
Mérieux Equity Partners SAS. (1/8/20). "Press Release: Mérieux Equity Partners Successfully Completes the Fundraising of Mérieux Participations 3". Lyon. |
2020-01-08 |
VectivBio AG. (1/7/20). "Press Release: VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases". Basel. |
2020-01-07 |
Novo Holdings A/S. (1/6/20). "Press Release: Novo Holdings REPAIR Impact Fund Invests USD 12 Million in Mutabilis and IBT Vaccines and Provides Strategic Update". Copenhagen. |
2020-01-06 |
Savara Inc.. (12/20/19). "Press Release: Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million". Austin, TX. |
2019-12-20 |
Genmab A/S. (12/19/19). "Press Release: Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics". Copenhagen & Tübingen. |
2019-12-19 |
Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. |
2019-12-19 |
Zelluna Immunotherapy AS. (12/19/19). "Press Release: Zelluna Immunotherapy Appoints Namir Hassan as Chief Executive Officer". Oslo. |
2019-12-19 |
Genomill Health. (12/18/19). "Press Release: Genomill Health Closes Investment Round to Expand Beta-testing with Liquid Biopsy Players". Turku. |
2019-12-18 |
BC Platforms AG. (12/18/19). "Press Release: BC Platforms Closes $15 Million Series C Financing and Signs Partnership with Iqvia to Extend Data Analytics in Genomics". Zürich & Boston, MA. |
2019-12-18 |
Alligator Bioscience AB. (12/17/19). "Press Release: First Patient Dosed with ATOR-1017 Developed for Metastasized Cancer". Lund. |
2019-12-17 |
Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". |
2019-12-16 |
Immunicum AB. (12/13/19). "Press Release: Immunicum AB (publ) Announces Resignation of Carlos de Sousa as CEO". |
2019-12-13 |
Genmab A/S. (12/13/19). "Press Release: CHMP Issues Positive Opinion Recommending Darzalex (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma". Copenhagen. |
2019-12-13 |
Alligator Bioscience AB. (12/11/19). "Press Release: CFO Per-Olof Schrewelius Leaves Alligator Bioscience". Lund. |
2019-12-11 |
Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. |
2019-12-10 |
BC Platforms AG. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. |
2019-12-06 |
Ferring Pharmaceuticals S.A.. (12/5/19). "Press Release: FerGene Announces Pivotal Phase 3 Study of Nadofaragene Firadenovec Met Its Primary Endpoint". Washington, DC. |
2019-12-05 |
Unibio International plc. (12/4/19). "Press Release: Mitsubishi Corporation Invests in, and Partners with, Unibio". London & Copenhagen. |
2019-12-04 |
Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. |
2019-12-02 |
BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. |
2019-12-02 |
European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". |
2019-11-29 |
Alligator Bioscience AB. (11/29/19). "Press Release: Alligator Bioscience AB Appoints Chief Operating Officer". Lund. |
2019-11-29 |
Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. |
2019-11-28 |
Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. |
2019-11-26 |
Veloxis Pharmaceuticals A/S. (11/25/19). "Press Release: Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis [Not for any jurisdiction where violation of law]". Copenhagen. |
2019-11-25 |
Asahi Kasei Corporation. (11/25/19). "Press Release: Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc. to Accelerate Transformation into a Global Health Care Company". Tokyo. |
2019-11-25 |
Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo. |
2019-11-25 |
GeNeuro S.A.. (11/25/19). "Press Release: GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm Agree to Launch a New Clinical Study of Temelimab in Multiple Sclerosis". Geneva. |
2019-11-25 |
Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA. |
2019-11-25 |
Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. |
2019-11-19 |
Novo Holdings A/S. (11/19/19). "Press Release: Novo Ventures and Broad Institute of MIT and Harvard Launch Drug Discovery »Greenhouse« to Drive Creation of Innovative New Therapies". Boston, MA. |
2019-11-19 |
Novo Nordisk A/S. (11/18/19). "Press Release: Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-related Cardio-metabolic Diseases". Lexington, MA & Bagsværd. |
2019-11-18 |